Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • QLD vs MRNA✓SelectedUSD · MRNAQLD vs MRNA performance historyLatest closeAs of+0.72%11/18
Stock and ETF performance explorer

QLD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+115.7%
MRNA return
+156.2%
Excess return
-40.5%
Maximum drawdown
-42.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.7%-4.8%+5.6%+1.0%
7D-8.9%-20.9%+11.9%-7.7%
30D-17.0%-13.3%-3.8%-16.4%
3M-17.8%+212.6%-230.3%-25.7%
6M-17.3%+309.0%-326.4%-29.9%
YTD+5.9%+567.3%-561.4%-19.1%
1Y+11.6%+689.7%-678.0%-17.9%
All+115.7%+156.2%-40.5%+84.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling